
Overview
Kathryn Bylow is a Hematologist and an Oncologist practicing medicine in Milwaukee, Wisconsin.
Dr. Bylow is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Liver Embolization, and Gastrostomy.
Dr. Bylow is board certified in Geriatric Medicine, Internal Medicine, and Medical Oncology. She is actively involved in clinical research, co-authoring 12 peer reviewed articles and participating in 6 clinical trials. Dr. Bylow is currently accepting new patients.
Specialties
Licenses
Board Certifications
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- PPO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
8800 W. Doyne Ave., Milwaukee, WI 53226
Additional Areas of Focus
Dr. Bylow has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
6 Clinical Trials
Froedtert And The Medical College Of Wisconsin Froedtert Hospital
Timothy Fenske is a Hematologist practicing medicine in Milwaukee, Wisconsin. Dr. Fenske is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Mantle Cell Lymphoma (MCL), Non-Hodgkin Lymphoma, B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Fenske is currently accepting new patients.
Froedtert Hospital
Dr. Joshua Field is an Associate Medical Director at the Versiti Blood Center of Wisconsin and an Assistant Professor of Medicine at the Medical College of Wisconsin. Dr. Field specializes in the treatment of sickle cell disease and other benign hematological disorders at Froedtert Hospital and Children’s Hospital of Wisconsin. Dr. Field graduated from the University of Iowa Medical School. He completed an Internal Medicine Residency and Fellowships in Hematology and Transfusion Medicine at Washington University in St. Louis, where he was Chief Resident in Internal Medicine and Chief Fellow in Hematology/Oncology. Dr. Field is Board Certified in Internal Medicine and Hematology. Dr. Field is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Hemolytic Anemia, Congenital Hemolytic Anemia, and Bone Marrow Aspiration. Dr. Field is board certified in Hematology and Internal Medicine. Dr. Field is currently accepting new patients.
Clinical Cancer Center - Froedtert Hospital
John Charlson is a Hematologist and an Oncologist practicing medicine in Milwaukee, Wisconsin. Dr. Charlson is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Synovial Sarcoma, and Undifferentiated Pleomorphic Sarcoma. Dr. Charlson is board certified in Medical Oncology. Dr. Charlson is currently accepting new patients.
Clinical Cancer Center - Froedtert Hospital
Dr. Kurzrock is a world-renowned leader in precision oncology and rare cancers research. She is the Associate Director of Clinical Research for the Medical College of Wisconsin Cancer Center, Associate Director of Precision Oncology at the Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine and the founding director of the Michels Rare Cancers Research Laboratories at the MCW Cancer Center. She is recognized as one of the world’s 25 most important voices in precision medicine and one of the most highly cited scientists globally. She has authored over 950 scientific and medical publications. Dr. Kurzrock is the Chair for the Early Therapeutics and Rare Cancers Committee (SWOG NCI) — one of the largest clinical trials cooperative groups in the country — and has been the principal investigator for more than 100 early-phase clinical trials, leading eight life-changing drugs to FDA approval. In 2022, Dr. Kurzrock and the DART rare cancer study team received the National Cancer Institute Director’s Award of Merit for outstanding work. Dr. Kurzrock is highly rated in 35 conditions, according to our data. Her clinical expertise encompasses PIK3CA-Related Overgrowth Spectrum, Castleman Disease, Multicentric Castleman Disease (MCD), Lymphoid Hyperplasia, and Tissue Biopsy. Dr. Kurzrock is board certified in Internal Medicine and Medical Oncology. Dr. Kurzrock is currently accepting new patients.
Clinical Cancer Center - Froedtert Hospital
Dr. Anita D’Souza is a professor of medicine (hematology/oncology). She completed her medical school from Goa Medical College, India where she graduated at the top of her class and was awarded Best Medical Graduate. She completed her internal medicine residency from William Beaumont Hospital in Michigan where she received the Zimmerman Award for Outstanding Clinical Judgment, Leadership, and Integrity. She completed her hematology/oncology fellowship from the Mayo Clinic in Rochester, Minnesota. She is a past recipient of the Daniel McCarty Award for Research Excellent and Women in Science Rising Pioneer Award at MCW. Dr. D'souza is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Primary Amyloidosis, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Tissue Biopsy. Dr. D'souza is board certified in Medical Oncology And Hematology and Internal Medicine. Dr. D'souza is currently accepting new patients.
Clinical Cancer Center - Froedtert Hospital
Binod Dhakal, MD, MS, is an associate professor of medicine (hematology and oncology) at the Medical College of Wisconsin, specializing in multiple myeloma and plasma cell disorders. He graduated from Manipal College of Medical Sciences, Pokhara Nepal in 2004, completed internal medicine residency at Saint Francis Hospital, Evanston, IL, and a fellowship in hematology/oncology at the Medical College of Wisconsin, where he also served as a chief fellow. Prior to joining the fellowship, he was an assistant professor of medicine (general internal medicine) at the Medical College in Wisconsin. He has authored numerous publications, including journal articles, meeting abstracts and book chapters. He has also won several awards during his fellowship which include the American Society of Clinical Oncology (ASCO) Merit Award; Medical College of Wisconsin Affiliated Hospitals (MCWAH) research award; Central Society for Clinical and Translational Research (CSCTR) best oral abstract and travel trainee award; American Society for Blood and Marrow Transplantation (ASBMT) clinical research training course; and, Outstanding Medical School Teacher award. Additionally, he was the recipient of the Mazie Froedtert Willms and Sue Froedtert Cancer Scholarship, and obtained his Master’s Degree in Clinical and Translational Science. His current research interests focus on novel drug treatments for patients with multiple myeloma and related plasma cell disorders by designing and conducting early phase clinical trials. Dr. Dhakal is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Dhakal is currently accepting new patients.
Frequently Asked Questions about Dr. Kathryn A. Bylow
How do I make an appointment with Dr. Kathryn A. Bylow?
You can book an appointment with Dr. Kathryn A. Bylow by calling their office at 414-805-0505. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Kathryn A. Bylow a top-rated expert for Prostate Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kathryn A. Bylow is classified as an Distinguished expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Kathryn A. Bylow specialize in?
While Dr. Kathryn A. Bylow is a Hematology, they have specific expertise in Prostate Cancer, Renal Cell Carcinoma (RCC), and Familial Prostate Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Kathryn A. Bylow participate in research or clinical trials?
Yes. Dr. Kathryn A. Bylow has published 12 articles and abstracts on conditions like Prostate Cancer. You can view a list of Dr. Kathryn A. Bylow's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Kathryn A. Bylow accept my insurance?
Dr. Kathryn A. Bylow accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 414-805-0505 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Adult Soft Tissue SarcomaDr. Bylow isDistinguished. Learn about Adult Soft Tissue Sarcoma.
- Chromophobe Renal Cell CarcinomaDr. Bylow isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Familial Prostate CancerDr. Bylow isDistinguished. Learn about Familial Prostate Cancer.
- Prostate CancerDr. Bylow isDistinguished. Learn about Prostate Cancer.
- Renal Cell Carcinoma (RCC)Dr. Bylow isDistinguished. Learn about Renal Cell Carcinoma (RCC).
- WT1-Related Wilms Tumor SyndromesDr. Bylow isDistinguished. Learn about WT1-Related Wilms Tumor Syndromes.
- Advanced
- Bladder CancerDr. Bylow isAdvanced. Learn about Bladder Cancer.
- Clear Cell SarcomaDr. Bylow isAdvanced. Learn about Clear Cell Sarcoma.
- Familial Wilms Tumor 2Dr. Bylow isAdvanced. Learn about Familial Wilms Tumor 2.
- Muscle Invasive Bladder CancerDr. Bylow isAdvanced. Learn about Muscle Invasive Bladder Cancer.
- Urothelial CancerDr. Bylow isAdvanced. Learn about Urothelial Cancer.
- Wilms TumorDr. Bylow isAdvanced. Learn about Wilms Tumor.
- Experienced
- AgranulocytosisDr. Bylow isExperienced. Learn about Agranulocytosis.
- ChoriocarcinomaDr. Bylow isExperienced. Learn about Choriocarcinoma.
- Chronic Familial NeutropeniaDr. Bylow isExperienced. Learn about Chronic Familial Neutropenia.
- Familial Pancreatic CancerDr. Bylow isExperienced. Learn about Familial Pancreatic Cancer.
- GastrostomyDr. Bylow isExperienced. Learn about Gastrostomy.
- Liver EmbolizationDr. Bylow isExperienced. Learn about Liver Embolization.
- Mediastinal TumorDr. Bylow isExperienced. Learn about Mediastinal Tumor.
- Non-Muscle Invasive Bladder CancerDr. Bylow isExperienced. Learn about Non-Muscle Invasive Bladder Cancer.
- Pancreatic CancerDr. Bylow isExperienced. Learn about Pancreatic Cancer.
- Penile CancerDr. Bylow isExperienced. Learn about Penile Cancer.
- Severe Congenital NeutropeniaDr. Bylow isExperienced. Learn about Severe Congenital Neutropenia.
- Teratoma of the MediastinumDr. Bylow isExperienced. Learn about Teratoma of the Mediastinum.
- Testicular CancerDr. Bylow isExperienced. Learn about Testicular Cancer.
- Upper Tract Urothelial Carcinoma (UTUC)
- Urachal CancerDr. Bylow isExperienced. Learn about Urachal Cancer.




